Interventional cardiology firm Radiance Medical Systems has enrolled the first group of U.S. patients in its RAPID (radiation after percutaneous transluminal angioplasty is done) peripheral vascular clinical trial. Three de-novo lesion cases were completed at Rush Presbyterian Hospital in Chicago, and all involved the beta irradiation of a portion of the superficial femoral artery.
The patients were treated using the Irvine, CA-based company’s RDX system by the institution’s interventional cardiologists. Radiance said the trial was the first in the U.S. to use beta radiation to treat arterial stenosis in a peripheral vessel. A total of 14 patients, in the U.S. and Europe, have been treated using the RAPID protocol.
By AuntMinnie.com staff writersDecember 7, 2001
Related Reading
Radiance applies for phase II BRITE trials, September 12, 2000
Radiance begins CE Mark process for RDX, September 6, 2000
Radiance posts higher revenues, lower sales, May 5, 2000
Copyright © 2001 AuntMinnie.com
